Bluebook
Pharma Services: Drug Development BlueBook January 2025
2025 - January: Report on M&A and financing activity in the pharma services drug development industry for CEOs and private equity professionals
Crosstree BlueBooks provide an executive review of key health sciences transactions, financial movements, and public market activity. BlueBooks also offer a glimpse of how valuations are changing and how recent trends may affect future transactions.
Highlights from this edition:
- Quartet Health was acquired by NeuroFlow
- Suvoda announced its acquisition of Greenphire
- Truveta closed a $320MM Series A Financing, led by Advocate Aurora Health, Regeneron Pharmaceuticals, and Northwell Health